F.D.A. to Relabel Leucovorin for Autism Treatment
The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.
The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.
